Total assets increased 16.0%
Total assets changed +16.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Total assets changed +16.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capital expenditure changed +49.7% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Revenue changed +15.0% from the comparable as-filed period.
Noncurrent long-term debt changed -21.2% from the comparable as-filed period.
Operating cash flow changed +7.9% from the comparable as-filed period.
Debt / revenue changed -1915 basis points from the comparable as-filed period.
Working capital / assets changed -359 basis points from the comparable as-filed period.
Receivables / revenue changed -213 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross debt changed +5.8% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Selling, general & administrative changed +15.4% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Free-cash-flow proxy changed +4.8% from the comparable as-filed period.
Capex / revenue changed +43 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Shares outstanding changed -0.3% from the comparable as-filed period. The change ranks at the 0th percentile of 8 prior comparable changes. This reverses 7 consecutive comparable moves in the opposite direction.
Trade receivables changed +11.6% from the comparable as-filed period.
Current long-term debt changed from 0 to 893900000 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
Inventory changed -9.5% from the comparable as-filed period.
Current ratio changed -17.9% from the comparable as-filed period.
Free-cash-flow margin changed -167 basis points from the comparable as-filed period.
Operating cash-flow margin changed -124 basis points from the comparable as-filed period.
Research & development changed +5.9% from the comparable as-filed period.
Working capital changed -7.1% from the comparable as-filed period.
R&D / revenue changed -55 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
SBC / revenue changed -36 basis points from the comparable as-filed period.
Cost of revenue changed -7.1% from the comparable as-filed period.
Stock-based compensation changed -8.7% from the comparable as-filed period.
Stock-based compensation changed +96.1% from the comparable as-filed period.
Total assets changed +16.7% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Revenue changed +16.2% from the comparable as-filed period.
Gross margin changed -93 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Receivables / revenue changed -722 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating income changed +131.6% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Research & development changed +20.8% from the comparable as-filed period.
Debt / revenue changed -2811 basis points from the comparable as-filed period.
Selling, general & administrative changed +19.8% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Gross debt changed +6.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +1613 basis points from the comparable as-filed period.
Working capital / assets changed +307 basis points from the comparable as-filed period.
Free-cash-flow margin changed +1611 basis points from the comparable as-filed period.
Inventory changed -15.3% from the comparable as-filed period.
Cost of revenue changed +20.9% from the comparable as-filed period.
Noncurrent long-term debt changed -8.4% from the comparable as-filed period.
Capex / revenue changed +3 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Current long-term debt changed from 0 to 497000000 USD in the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a zero base.
SBC / revenue changed +90 basis points from the comparable as-filed period.
Capital expenditure changed +18.0% from the comparable as-filed period.
Shares outstanding changed +0.6% from the comparable as-filed period. The change ranks at the 38th percentile of 8 prior comparable changes.
Trade receivables changed +4.7% from the comparable as-filed period.
R&D / revenue changed +31 basis points from the comparable as-filed period.
Current ratio changed -0.1% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.